about
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirementsBiological interactions of carbon-based nanomaterials: From coronation to degradation.Emerging therapeutic delivery capabilities and challenges utilizing enzyme/protein packaged bacterial vesiclesBiological potential of nanomaterials strongly depends on the suspension media: experimental data on the effects of fullerene C₆₀ on membranes.A zeta potential value determines the aggregate's size of penta-substituted [60]fullerene derivatives in aqueous suspension whereas positive charge is required for toxicity against bacterial cellsLiposome formulation of fullerene-based molecular diagnostic and therapeutic agents.When a nanoparticle meets a superhalogen: a case study with C60 fullerene.Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.Theoretical identification of seven C80 fullerene isomers by XPS and NEXAFS spectroscopy.Characterizing the Nano-Bio Interface Using Microscopic Techniques: Imaging the Cell System is Just as Important as Imaging the Nanoparticle System.C60 Fullerenes Diminish Muscle Fatigue in Rats Comparable to N-acetylcysteine or β-Alanine.C60 Bioconjugation with Proteins: Towards a Palette of Carriers for All pH Ranges.Use of Cyclodextrins in Anticancer Photodynamic Therapy TreatmentC fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes
P2860
Q26744352-A470CB5C-8DE8-4D49-9706-115D3CEE094CQ26771906-14CAC2CD-6B81-4167-B0A8-D511962ECB5BQ26801293-C9252D3F-7705-4A3F-98D6-A91C6095A8BAQ35592609-E55A5D23-FF06-498A-829F-2410EFF2F3D3Q35740168-8F4D2A4F-7904-4891-BED1-DCDA60A52A68Q37415965-00B6E6B9-291E-47FD-B21A-BF3619AD9A14Q38848305-440052ED-E759-43EF-822A-267B35CA1FBFQ38896543-C3A25302-AEB7-426A-80AD-FF549B54FFC5Q49383387-7DDD1F1C-0F44-40AF-8DA6-624463D38B8CQ50089912-E3783F4E-63EF-47E0-8B75-2FEA5BF3CECBQ54963897-58754A9D-000A-447E-8EC4-69A49D658D3DQ55333119-0F449605-DBD1-4C08-96F9-E4898C1621A6Q58692471-A9FDD98F-537D-4074-8FBA-EA3CC68366F9Q58703382-0890F95B-BAF7-41F3-8406-366989ADAE26
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Application of fullerenes in nanomedicine: an update.
@ast
Application of fullerenes in nanomedicine: an update.
@en
Application of fullerenes in nanomedicine: an update.
@nl
type
label
Application of fullerenes in nanomedicine: an update.
@ast
Application of fullerenes in nanomedicine: an update.
@en
Application of fullerenes in nanomedicine: an update.
@nl
prefLabel
Application of fullerenes in nanomedicine: an update.
@ast
Application of fullerenes in nanomedicine: an update.
@en
Application of fullerenes in nanomedicine: an update.
@nl
P2093
P2860
P356
P1433
P1476
Application of fullerenes in nanomedicine: an update.
@en
P2093
A B Madhankumar
Anthony Dellinger
Christie M Sayes
Christopher L Kepley
James Connor
Sarala Pamujula
Zhiguo Zhou
P2860
P304
P356
10.2217/NNM.13.99
P577
2013-07-01T00:00:00Z